Die Suchmaschine für Unternehmensdaten in Europa

EU-Förderung (9.280.000 €): Gravitate-Gesundheit: Stärkung und Ausstattung der Europäer mit Gesundheitsinformationen für aktives persönliches Gesundheitsmanagement und die Einhaltung der Behandlung Hor 01.11.2020 EU-Rahmenprogramm für Forschung und Innovation "Horizont"

Text

Gravitate-Gesundheit: Stärkung und Ausstattung der Europäer mit Gesundheitsinformationen für aktives persönliches Gesundheitsmanagement und die Einhaltung der Behandlung

The Gravitate-Health mission is to equip and empower citizens with digital information tools that make them confident, active, and responsive in their patient journey, specifically encouraging safe use of medicines for better health outcomes and quality of life. It is our vision that engagement of citizens in their own health can only be achieved with access to actionable, understandable, relevant, reliable and evidence-based information that meets their specific needs, health context, and literacy level. This project's ambition is to provide a key piece to advance this vision: the Gravitate Lens (G-lens), which focuses (but does not conceal or filter) approved electronic product information (ePI) content, and offers a route for patients to access trustworthy, up-to-date information that better meet their individual needs. Gravitate-Health is an integrated digital health information project. The principle objective is to demonstrate how use of an integrated, digital, user-centric health information solution with two-way communication could enable tangible improvements in availability and understanding of health information from a set of trusted sources, starting with regulator-approved medicinal product information (e.g. package leaflet content) and EHR-IPS (International Patient Summary). The secondary objectives are to demonstrate that the improved availability and understanding of health information from trusted sources translate to higher levels of adherence to treatment, safer use of medication (Pharmacovigilance), better health outcomes and quality of life, and to develop new and deeper insights into how use of available health information can be optimized to act as effective risk minimization measures. The project allows for efficient and timely development of the G-lens, provides testing grounds for new services and an evaluation framework to test the efficiency, efficacy and safety of Gravitate-Health services. Our main outputs will be an open source digital platform supporting G-lens functionally, demonstrated in a number of testing scenarios, and a White Paper with recommendations on realistic strategies to strengthen access, understanding and future use of digital services like ePIs as a tool for Risk Minimization. The Gravitate-Health is a public – private partnership with 45 members from Europe and the US, co-led by University of Oslo (coordinator) and Pfizer (industry lead), funded by the Innovative Medicines Initiative (IMI) – a joint undertaking of the European Commission, the European Federation of Pharmaceutical Industries and Associations (EFPIA), IMI Associated Partners.


Geförderte Unternehmen:

Firmenname Förderungssumme
Agencia Espanola de Medicamentos y Productos Sanitarios 70.000 €
Agentschap College TER Beoordeling Van Geneesmiddelen 197.375 €
Akershus Universitetssykehus HF 344.375 €
Astrazeneca AB 0,00 €
Bayer AG 0,00 €
Beth Israel Deaconess Medical Center, INC NON Profit Corporation 0,00 €
Datapharm Ltd. 0,00 €
Datawizard Srl 402.313 €
Direktoratet FOR Medisinske Produkter 1.325,18 €
DLI - Dansk Laegemiddel Information A/S 22.501 €
Echalliance CLG 286.500 €
Eli Lilly and Company Ltd. 0,00 €
Empirica Gesellschaft FUR Kommunikations UND Technologieforschung mbH 534.554 €
F. Hoffmann-LA Roche AG 0,00 €
Felleskatalogen AS 33.751 €
Forum des Patients Europeens 302.725 €
Frisq Holding AB 106.838 €
Grunenthal GmbH 0,00 €
Guardtime OÜ 117.656 €
Himss Europe GmbH 268.375 €
HL7 Europe 729.429 €
Janssen Pharmaceutica N.V. 0,00 €
Karolinska Institutet 367.466 €
Kobenhavns Universitet 126.250 €
Lakemedelsindustriforeningens Service AB 22.501 €
Mdsol Europe Ltd. 0,00 €
Mindview Symvouloi Epixeiriseon Kaierevnas Etaireia Periorismenis Efthynis 149.625 €
Mylan IRE Healthcare Ltd. 0,00 €
Norsk E Helse AS 296.250 €
Novartis Pharma AG 0,00 €
Open Evidence 61.107 €
Oslo Universitetssykehus HF 155.000 €
Pfizer Ltd. 0,00 €
Pharmaca Health Intelligence Oy 22.501 €
Predictby Research And Consulting SL 296.345 €
Servicio Madrileno de Salud 142.481 €
SPMS - Servicos Partilhados do Ministerio da Saude ΕΠΕ 141.000 €
Synergist Services 0,00 €
THE European Institute for Innovation Through Health Data 273.304 €
The Provost, Fellows Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near Dublin 336.491 €
THE Synergist 249.000 €
Trifork Digital Health AS 431.407 €
UCB Biopharma 0,00 €
Universidad Politecnica de Madrid 609.554 €
Universita Cattolica Del Sacro Cuore 151.813 €
Universitetet I Oslo 1.860.565 €
Universitetssykehuset Nord-Norge HF 163.750 €
University College Dublin, National University of Ireland, Dublin 5.875,00 €

Quelle: https://cordis.europa.eu/project/id/945334

Diese Bekanntmachung wurde von Englisch nach Deutsch übersetzt. Die Bekanntmachung bezieht sich auf einen vergangenen Zeitpunkt, und spiegelt nicht notwendigerweise den heutigen Stand wider.